Powerhouse Ventures Ltd. · ASX:PVL
Powerhouse Ventures — H1 FY2023 Earnings Presentation
11 slides from Powerhouse Ventures's earnings presentation, Feb 24, 2023
Slide 1: Powerhouse Ventures Limited 1H FY23 Results Presentation
Powerhouse Ventures Limited 1H FY23 Results Presentation ASX:PVL 24 February 2023
Slide 2: Disclaimer
Disclaimer This Presentation contains certain “forward-looking statements”. The words “expect”, “anticipate”, “estimate”, “intend”, “believe”, “guidance”, “should”, “could”, “may”, “will”, “predict”, “plan” and other similar expressions are intended to identify forward-looking statements. Indication
Slide 3: 1H FY23 Financial Results
1H FY23 Financial Results + 1.8c on PCP1 + $350,641 on PCP1 NTA Per Share + $1,782,143 9.1c on PCP1 Net Operating Cash + $1,472,773 -$179,094 on PCP1 Profit After Tax $1,003,451 Revaluation Gains $994,243 1. Prior Comparative Period (PCP) 6 months ended 31 December 2021
Slide 4: Investment Portfolio Growth
Investment Portfolio Growth Acquisition was investment into Liquid Instruments Largest revaluation gains were Skykraft & Ferronova Favourable FX especially USD, CAD Interest on Convertible Notes
Slide 5: Profit/loss & Net Operating Cash
Profit/loss & Net Operating Cash $1,000,000 $800,000 $600,000 $400,000 $200,000 1H FY23 profit driven by revaluation gains $0 Net cash from Operating ($200,000) Activities remains low per PVL strategy ($400,000) ($600,000) ($800,000) Dec-21 Jun-22 Dec-22 Profit/loss after tax Net cash from Operating
Slide 6: NTA & Share Performance
NTA & Share Performance 12c 11.0c 11c NTA 1.0c gain exceeded 10c 9.5c top end guidance of 0.8c 9.1c 9.1c issued on 22/12/22 9c 8.1c 8.1c 8c 7.6c NTA steadily increasing 7.3c 7.0c 7c 6.5c 6.3c PVL views NTA growth as 6c the long-term driver of 5.3c share price 5c 4c Dec-21 Mar-22 Jun-22 Sep-22 Dec-22
Slide 7: Relative Performance
Relative Performance 130.0 120.0 110.0 100.0 Rebased to 100 90.0 Share price correlated with markets 80.0 70.0 60.0 50.0 40.0 Dec-21 Mar-22 Jun-22 Sep-22 Dec-22 NTA Share Price XSO.AX NASDAQ
Slide 8: Recent Media of Portfolio
Recent Media of Portfolio e @ skvKrarT #6 ferronova Canberra company Skykraft launches Australian biotech startup Ferronova secures A$11M to satellites onboard SpaceX rocket in bid to advance nanotech image-guided cancer therapy improve air traffic management ama 2025 Ne ponies bys can A ln. 2025, F
Slide 9: Corporate Snapshot
Corporate Snapshot Overview at 31/12/22 Personnel Auditor / Consultants Shares on Issue: 120,743,176 James Kruger Executive Chairman Options: 12,227,631 Joshua Baker Director Market Cap: $6,399,388 Joe Demase Director Cash: $3,246,995 Sally McDow Company Secretary Cash runway*: > 5 years Geoffrey Ni
Slide 10: Investment History
Investment History 2022 2021 ≤ 2020 Liquid Instruments CourseLoop Cirrus Materials Cirrus (follow on) Firmus Grid CertusBio Quantum Brillance Skykraft Inhibit Coatings Urbix Ferronova Neuroflex Olympio Metals Flomatrix *Veritide *Deliveon Health *Fluent Scientific *Hi-Aspect *Avalia Immunotherapies
Slide 11: Thank you
Thank you For further information contact: James Kruger Executive Chairman jk@phvl.com.au +61 499 980 623 Ben Hodge Chief Investment Officer bh@phvl.com.au +61 416 876 117
Powerhouse Ventures — H1 FY2023 Earnings Presentation on 6ix